Skip to content

Effect of Boswellia in treatment of knee Osteoarthritis

Evaluation of the effectiveness of frankincense oily lotion containing boswellic acid enriched extract in the treatment of knee osteoarthritis symptoms: a randomized placebo-controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150721023282N14
Enrollment
50
Registered
2020-09-20
Start date
2020-07-18
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. M17.1

Interventions

Intervention 1: Intervention group: Oily lotion of frankincense extract containing 65% boswellic acid (manufactured by Fardis pharmaceutical company), 3 times daily for 4 weeks. Intervention 2: Contro

Sponsors

Fardis pharmaceutical company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: age of 40 - 80 years Osteoarthritis of at least one knee for at least 3 months based on the diagnostic criteria of American College of Rheumatology (ACR) Pain score > 4 mm based on the Visual Analogue Scale (VAS) Grade 2 or 3 of Kellgren-Lawrence scale in knee radiography within the past 3 months

Exclusion criteria

Exclusion criteria: Use of intra-articular glucocorticoids within the past 3 months Use of intra-articular sodium hyaluronate within the past 6 months Use of systemic glucocorticoids (either oral or parenteral) within the past 14 days Having other osteoarticular disorders (e.g., rheumatoid arthritis and gout) Skin disorder in knee region Sensitivity to prescribed topical formulations Knee arthroscopy within the past 3 months Illiteracy Unable to answer the questions Pregnancy Lactation

Design outcomes

Primary

MeasureTime frame
WOMAC Index. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Questionnaire.;Visual analogue scale (VAS). Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: scoring on the scale.;Patient global assessment (PGA). Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: scoring on the scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Soltani

Esfahan University of Medical Sciences

soltani@pharm.mui.ac.ir+98 31 3792 7067

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026